Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.
26 August 2022 (08:00 - 19:30)
Organised by:
About the speaker

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
5 More presentations in this session

Doctor J. Miyamoto (Kanagawa, JP)
Access the full session
The Event
ESC Congress 2022
26 August - 29 August 2022
You may be interested in
Congress Presentation





